Literature DB >> 3004719

Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung.

R A Stahel, C J O'Hara, M Mabry, R Waibel, K Sabbath, J A Speak, S D Bernal.   

Abstract

The reactivity of the murine immunoglobulin monoclonal antibody LAM8 directed against a membrane antigen of human small cell carcinoma (SCC) of the lung was investigated on human cell lines and tissues. Indirect immunofluorescence staining, radioimmunoassays, and cytotoxicity assays showed LAM8 antibody to selectively react with SCC but not with non-SCC lung cancer cell lines and extrapulmonary tumor cell lines. Unlike other SCC antibodies, including those we have previously described, highly preferential reactivity with SCC tissues was also demonstrated by immunoperoxidase staining of deparaffinized formalin-fixed tissue sections. Membrane and cytoplasmic staining was seen in of 9 of 12 SCC tissues. No significant staining was seen in non-SCC lung cancer and a wide range of other tumors, including mesothelioma and bronchial carcinoids. Significant LAM8 reactivity was also absent in normal tissues of all major organs. Few tumors and epithelial tissues, including bronchial epithelium had rare LAM8 positive cells which were always less than 2% of the entire cell population. In vitro treatment with antibody and human complement was highly cytotoxic to SCC cells, but had not effect on bone marrow progenitor cells. Immunoblotting of membrane extracts separated on sodium dodecyl sulfate-polyacrylamide gels showed the LAM8 antigen to have a band of an approximate molecular weight of 135,000 and a cluster of bands with approximate molecular weights of 90,000. This reactivity was lost after incubation of the extracts with periodate. LAM8 antibody shows a highly preferential reactivity with SCC cell lines and formalin-fixed paraffin-embedded SCC tissues and is selectively cytotoxic to cells expressing LAM8 antigen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004719

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.

Authors:  C Zwicky; R A Stahel; H Jaksche; R Waibel; H P Lehmann; H Loibner
Journal:  Br J Cancer Suppl       Date:  1991-06

2.  Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.

Authors:  A T Myklebust; K Beiske; A Pharo; C D Davies; S Aamdal; O Fodstad
Journal:  Br J Cancer Suppl       Date:  1991-06

3.  Membrane antigens of human bronchial epithelial cells identified by monoclonal antibodies.

Authors:  S Bernal; K Weinberg; M Kakefuda; R Stahel; C O'Hara; Y C Wong
Journal:  In Vitro Cell Dev Biol       Date:  1988-02

4.  Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11.

Authors:  A Smith; R Waibel; G Westera; A Martin; A T Zimmerman; R A Stahel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

5.  Expression of the small cell carcinoma antigens of cluster-5 and cluster-5A in primary lung tumours.

Authors:  A Maier; U Schmidt; R Waibel; W Hartung; R A Stahel
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.